315 related articles for article (PubMed ID: 17666524)
1. Effect of deficiency in SREBP cleavage-activating protein on lipid metabolism during intermittent hypoxia.
Li J; Nanayakkara A; Jun J; Savransky V; Polotsky VY
Physiol Genomics; 2007 Oct; 31(2):273-80. PubMed ID: 17666524
[TBL] [Abstract][Full Text] [Related]
2. Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha.
Li J; Bosch-Marce M; Nanayakkara A; Savransky V; Fried SK; Semenza GL; Polotsky VY
Physiol Genomics; 2006 May; 25(3):450-7. PubMed ID: 16507783
[TBL] [Abstract][Full Text] [Related]
3. Intermittent hypoxia induces hyperlipidemia in lean mice.
Li J; Thorne LN; Punjabi NM; Sun CK; Schwartz AR; Smith PL; Marino RL; Rodriguez A; Hubbard WC; O'Donnell CP; Polotsky VY
Circ Res; 2005 Sep; 97(7):698-706. PubMed ID: 16123334
[TBL] [Abstract][Full Text] [Related]
4. Blunted feedback suppression of SREBP processing by dietary cholesterol in transgenic mice expressing sterol-resistant SCAP(D443N).
Korn BS; Shimomura I; Bashmakov Y; Hammer RE; Horton JD; Goldstein JL; Brown MS
J Clin Invest; 1998 Dec; 102(12):2050-60. PubMed ID: 9854040
[TBL] [Abstract][Full Text] [Related]
5. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes.
Horton JD; Shah NA; Warrington JA; Anderson NN; Park SW; Brown MS; Goldstein JL
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12027-32. PubMed ID: 14512514
[TBL] [Abstract][Full Text] [Related]
6. The nuclear receptor FXR uncouples the actions of miR-33 from SREBP-2.
Tarling EJ; Ahn H; de Aguiar Vallim TQ
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):787-95. PubMed ID: 25593129
[TBL] [Abstract][Full Text] [Related]
7. Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis.
Drager LF; Jun J; Polotsky VY
Curr Opin Endocrinol Diabetes Obes; 2010 Apr; 17(2):161-5. PubMed ID: 20125003
[TBL] [Abstract][Full Text] [Related]
8. SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation.
Matsuda M; Korn BS; Hammer RE; Moon YA; Komuro R; Horton JD; Goldstein JL; Brown MS; Shimomura I
Genes Dev; 2001 May; 15(10):1206-16. PubMed ID: 11358865
[TBL] [Abstract][Full Text] [Related]
9. Obstructive sleep apnea and dyslipidemia: from animal models to clinical evidence.
Barros D; García-Río F
Sleep; 2019 Mar; 42(3):. PubMed ID: 30476296
[TBL] [Abstract][Full Text] [Related]
10. Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice.
Li J; Grigoryev DN; Ye SQ; Thorne L; Schwartz AR; Smith PL; O'Donnell CP; Polotsky VY
J Appl Physiol (1985); 2005 Nov; 99(5):1643-8. PubMed ID: 16037401
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis.
Engelking LJ; Kuriyama H; Hammer RE; Horton JD; Brown MS; Goldstein JL; Liang G
J Clin Invest; 2004 Apr; 113(8):1168-75. PubMed ID: 15085196
[TBL] [Abstract][Full Text] [Related]
12. The discrete and combined effect of SREBP-2 and SCAP isoforms in the control of plasma lipids among familial hypercholesterolaemia patients.
Durst R; Jansen A; Erez G; Bravdo R; Butbul E; Ben Avi L; Shpitzen S; Lotan C; Leitersdorf E; Defesche J; Friedlander Y; Meiner V; Miserez AR
Atherosclerosis; 2006 Dec; 189(2):443-50. PubMed ID: 16466730
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of dysregulation of low-density lipoprotein receptor expression in HepG2 cells induced by inflammatory cytokines.
Chen YX; Ruan XZ; Huang AL; Li Q; Moorhead JF; Varghese Z
Chin Med J (Engl); 2007 Dec; 120(24):2185-90. PubMed ID: 18167199
[TBL] [Abstract][Full Text] [Related]
14. Increased hepatic INSIG-SCAP-SREBP expression is associated with cholesterol metabolism disorder in assisted reproductive technology-conceived aged mice.
Le F; Lou HY; Wang QJ; Wang N; Wang LY; Li LJ; Yang XY; Zhan QT; Lou YY; Jin F
Reprod Toxicol; 2019 Mar; 84():9-17. PubMed ID: 30562550
[TBL] [Abstract][Full Text] [Related]
15. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation.
Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
Cardiovasc Res; 2013 Dec; 100(3):450-60. PubMed ID: 24068000
[TBL] [Abstract][Full Text] [Related]
16. Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease.
Wu Y; Ma KL; Zhang Y; Wen Y; Wang GH; Hu ZB; Liu L; Lu J; Chen PP; Ruan XZ; Liu BC
Liver Int; 2016 Oct; 36(10):1525-34. PubMed ID: 27028410
[TBL] [Abstract][Full Text] [Related]
17. siRNA-mediated inhibition of SREBP cleavage-activating protein reduces dyslipidemia in spontaneously dysmetabolic rhesus monkeys.
Murphy BA; Tadin-Strapps M; Jensen K; Mogg R; Liaw A; Herath K; Bhat G; McLaren DG; Previs SF; Pinto S
Metabolism; 2017 Jun; 71():202-212. PubMed ID: 28521874
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose-drinking mice.
Mastrocola R; Collino M; Rogazzo M; Medana C; Nigro D; Boccuzzi G; Aragno M
Am J Physiol Gastrointest Liver Physiol; 2013 Sep; 305(6):G398-407. PubMed ID: 23868406
[TBL] [Abstract][Full Text] [Related]
19. The cellular function of SCAP in metabolic signaling.
Lee SH; Lee JH; Im SS
Exp Mol Med; 2020 May; 52(5):724-729. PubMed ID: 32385422
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent effects of siRNA-mediated inhibition of SCAP on PCSK9, LDLR, and plasma lipids in mouse and rhesus monkey.
Jensen KK; Tadin-Strapps M; Wang SP; Hubert J; Kan Y; Ma Y; McLaren DG; Previs SF; Herath KB; Mahsut A; Liaw A; Wang S; Stout SJ; Keohan C; Forrest G; Coelho D; Yendluri S; Williams S; Koser M; Bartz S; Akinsanya KO; Pinto S
J Lipid Res; 2016 Dec; 57(12):2150-2162. PubMed ID: 27707816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
